Additionally, CoQ10 acts as an antioxidant, helping to combat harmful free radicals and defend cells against oxidative damage.164 Moreover, mitofusin agonists have emerged as a promising potential treatment for CMT2A, as they directly target the MFN2 mutations. Here, MFN2 is linked to Charcot-Marie-Tooth disease type 2A1.